The role of diuretics in the treatment of arterial hypertension: focus on new loop diuretic - torasemide

Cover Page

Cite item

Full Text

Abstract

We show the pharmacoepidemiology review concerning diuretics usage for the treatment of arterial hypertension, the role of loop diuretics, in particular torasemide.

About the authors

M. V Leonova

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: anti23@mail.ru
д-р мед. наук, проф., чл.-кор. РАЕН, ГБОУ ВПО РНИМУ им. Н.И.Пирогова, проф. каф. клинической фармакологии ГБОУ ВПО РНИМУ им. Н.И.Пирогова 17997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

References

  1. Fukuda M, Kimura G. Pathophysiology of antihypertensive therapy with diuretics. Hypertens Res 2006; 29: 645-53.
  2. Collins R, Peto R, Mac Mahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2: Short - term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
  3. Law M.R, Morris J.K, Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta - analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
  4. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke 2003; 34: 2741-9.
  5. Psaty B.M, Lumley T, Furberg C.D et al. Health outcomes associated with various antihypertensive therapies used as first - line agents: a network meta - analysis. JAMA 2003; 289: 2534-4.
  6. Wright J.M, Musini V.M. First - line drugs for hypertension. Cohrane Database Syst Rev 2009; 8; 3: CD001841.
  7. Xue H, Lu Z, Tang W.L et al. First - line drugs inhibiting the renin angiotensin system versus other first - line antihypertensive drug classes for hypertension. Cochrane Database Syst Rev 2015; 11; 1: CD008170.
  8. Mancia G, Fagard R et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-357.
  9. Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр), 2010.
  10. Elliott W, Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta - analysis. Lancet 2007; 369: 201-7.
  11. Kent S.T, Shimbo D, Huang L et al. Antihypertensive Medication Classes Used among Medicare Beneficiaries Initiating Treatment in 2007-2010. PLoS ONE 2015; 9(8): e105888. doi: 10.1371/journal.pone.0105888.
  12. Леонова М.В., Белоусов Ю.Б., Штейнберг Л.Л., Галицкий А.А. Результаты фармакоэпидемиологического исследования артериальной гипертонии ПИФАГОР III (опрос пациентов с АГ). Системные гипертензии. 2010; 2: 33-9.
  13. Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии. 2010; 3: 5-26.
  14. Girvin B, Johnston D. Diuretics: guide to properties and efficacy in hypertension. Prescriber 2010; 20 (23-24): 17-30.
  15. Schmieder R.E, Rockstroh J.K. Efficacy of low dose loop diuretics in hypertension. Cardiology 1994; 84 (Suppl. 2): 36-42.
  16. Musini V.M, Rezapour P, Wright J.M et al. Blood pressure lowering efficacy of loop diuretics for primary hypertension. Cochrane Database Syst Rev 2012; 8: CD003825.
  17. K⁄DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 (Suppl. 1): S1-290.
  18. Tamargo J, Segura J, Ruilope L.M. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium - sparing agents. Exp Opin Pharmacother 2014; 15 (5): 605-21.
  19. Luft F.C. Torasemide in the treatment of arterial hypertension. J Cardiovasc Pharmacol 1993; 22 (Suppl. 3): S32-S39.
  20. Dunn C.J, Fitton A, Brogden R.N. Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drugs 1995; 49: 121-42.
  21. Coca A. Long term blood pressure control and metabolic disorders induced by torasemide in hypertension. AJH 2001; 14 (4): 116A.
  22. Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther 1993; 7 (Suppl. 1): 63-8.

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies